Not precisely. Though equally target GLP-one receptors, Tirz also activates GIP receptors, making it a dual agonist. This broader mechanism is considered to improve its results on insulin sensitivity and hunger signaling in exploration products. El reto farmacológico de esta clase de moléculas es el equilibrium entre las tres actividades: https://peptisell.com/product/tirzepatide